• 1. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 2. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197

Introduction to Methyl azepane-4-carboxylate (CAS No. 1211596-98-3)

Methyl azepane-4-carboxylate, a compound with the chemical formula C₈H₁₁NO₂ and a CAS number of 1211596-98-3, is a significant molecule in the field of pharmaceutical chemistry. This compound belongs to the azepane class, which is characterized by a seven-membered lactam ring system. The presence of a carboxylate ester group at the 4-position of the azepane ring imparts unique chemical and biological properties, making it a valuable intermediate in the synthesis of various pharmacologically active agents.

The synthesis of methyl azepane-4-carboxylate involves multi-step organic reactions, typically starting from readily available precursors such as cyclohexanone and ammonia derivatives. The key step in its synthesis is the formation of the azepane ring through cyclization reactions, followed by esterification to introduce the carboxylate moiety. Advanced synthetic methodologies, including transition metal-catalyzed reactions and enzymatic transformations, have been explored to enhance the yield and purity of this compound.

In recent years, methyl azepane-4-carboxylate has garnered attention in the development of novel therapeutic agents. Its structural motif is reminiscent of several bioactive molecules that exhibit significant pharmacological effects. For instance, derivatives of azepane have been investigated for their potential in treating neurological disorders due to their ability to interact with central nervous system receptors. The carboxylate group further enhances its solubility and bioavailability, making it an attractive scaffold for drug design.

One of the most compelling applications of methyl azepane-4-carboxylate is in the field of pain management. Researchers have identified that certain analogs of this compound exhibit potent analgesic properties by modulating neurotransmitter pathways. Specifically, studies have shown that modifications at the 4-position of the azepane ring can significantly alter its binding affinity to opioid receptors, leading to improved efficacy and reduced side effects compared to traditional analgesics. This discovery has opened new avenues for developing next-generation painkillers with enhanced safety profiles.

The role of methyl azepane-4-carboxylate in medicinal chemistry extends beyond pain management. It has been explored as a precursor for antipsychotic and antidepressant drugs. The seven-membered lactam ring provides a stable framework that can be further functionalized to target specific neurotransmitter systems involved in mood regulation. Recent studies have demonstrated that certain derivatives of methyl azepane-4-carboxylate exhibit significant antidepressant activity by inhibiting serotonin reuptake transporters. This finding underscores the compound's potential as a lead molecule in psychiatric drug development.

Another area where methyl azepane-4-carboxylate has shown promise is in anti-inflammatory therapy. Chronic inflammation is a hallmark of many diseases, including arthritis and autoimmune disorders. Researchers have found that compounds derived from azepane can modulate inflammatory pathways by interacting with cytokine receptors and enzymes involved in prostaglandin synthesis. Methyl azepane-4-carboxylate, with its versatile chemical structure, offers a platform for designing molecules that can selectively inhibit inflammatory responses without compromising host defense mechanisms.

The pharmacokinetic properties of methyl azepane-4-carboxylate are also worth mentioning. The carboxylate ester group enhances its metabolic stability while maintaining good solubility in both water and lipids. This balance is crucial for achieving optimal absorption, distribution, metabolism, and excretion (ADME) profiles in vivo. Additionally, the compound's low toxicity profile makes it an attractive candidate for clinical development. Preclinical studies have shown that methyl azepane-4-carboxylate exhibits minimal hepatotoxicity and nephrotoxicity, even at high doses.

In conclusion, methyl azepane-4-carboxylate (CAS No. 1211596-98-3) is a multifaceted compound with significant potential in pharmaceutical applications. Its unique structural features make it an excellent scaffold for designing drugs targeting various therapeutic areas, including pain management, psychiatry, and anti-inflammation. As research continues to uncover new biological activities associated with azepane derivatives, methyl azepane-4-carboxylate is poised to play a pivotal role in the development of next-generation therapeutics.

• 7462-86-4(methyl piperidine-4-carboxylate;hydrochloride)
• 1160245-55-5(Methyl 2-(piperidin-4-yl)propanoate)
• 782493-76-9(1H-Azepine-4-carboxylic acid, hexahydro-, methyl ester, (4R)-)
• 1383132-15-7(Methyl azepane-4-carboxylate hydrochloride)
• 892493-16-2(methyl 4-methylpiperidine-4-carboxylate)
• 2971-79-1(Methyl piperidine-4-carboxylate)
• 782493-75-8(1H-Azepine-4-carboxylicacid, hexahydro-, methyl ester, (4S)-)
• 1185013-13-1(Methyl 2-piperidin-4-ylpropanoate Hydrochloride)
• 782493-80-5(methyl azocane-5-carboxylate)
• 845909-33-3(methyl 3-methylpiperidine-4-carboxylate)